A randomized phase II study of secondary cytoreductive surgery in patients with relapsed ovarian cancer who have progressed on a PARP inhibitor as first-line maintenance therapy: the SOCCER-P study (KGOG 3067/JGOG 3036/APGOT-OV11)
Hyun-Woong Cho, Hee-Seung Kim, Jeong-Yeol Park, Yoo Young Lee, Myong Cheol Lim, Sung-Jong Lee, Kyung-Jin Min, Kyung Jin Eoh, Kwang Beom Lee, Min Kyu Kim, Jae Yun Song, Seung-Hyuk Shim, Yong Il Ji, Yong-Joong Song, Suk-Joon Chang, Mi Kyung Kim, Akiko Abe, Yusuke Kobayashi, Hiroaki Kajiyama, Muneaki Shimada, Aikou Okamoto, Joseph S Ng, Jung-Yun Lee
International Journal of Gynecologic Cancer Aug 2024, ijgc-2024-005838; DOI: 10.1136/ijgc-2024-005838
